Cervical

New York, USA, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Cervical Dysplasia Market Size and Share to Rise by 2032, Assesses DelveInsight | Key Companies - GlaxoSmithKline, Merck, Frantz Viral, Brooklyn ImmunoTherapeutics, PapiVax, Inovio …

Wilmington, Delaware, United States, July 06, 2023 (GLOBE NEWSWIRE) -- The global cervical cancer diagnostic tests market stood at US$ 8.7 billion in 2021, and the global market is projected to reach US$ 13.6 billion by 2031. The global…

New York, USA, June 22, 2023 (GLOBE NEWSWIRE) -- Cervical Cancer Market Size is Likely to Increase, Examines DelveInsight | Key Companies in the Market - Gilead, Roche, Genentech, Iovance, Bristol-Myers Squibb, Exelixis, Xencor, Merck,…

Elana Gotkine THURSDAY, June 1, 2023 (HealthDay News) -- For women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab,…

OSLO, Norway, June 01, 2023 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has expanded the…

<!-- Name:DistributionId Value:1000810103 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5500 -->…

<!-- Name:DistributionId Value:8830171 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4535 -->…

<!-- Name:DistributionId Value:8829244 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True --> <!-- Name:IcbCode Value:4535 -->…

Lori Solomon THURSDAY, April 6, 2023 (HealthDay News) -- Women with severe mental illness have lower rates of cancer screening and experience a higher risk for cervical neoplasia, according to a study…

<!-- Name:DistributionId Value:8802984 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4535 -->…